Risk of Fluctuations in Stock Market Conditions and Exchange Rates
First written in FY2016. 1 of 2 entries say "Reframed", first in FY2018. Latest entry: FY2018.
JCR Pharmaceuticals moved to the "Worse" side of this theme in 2018, 1 year before the typical company in this theme (2019).
The whole theme swung hardest in 2019: 13 of 16 companies on the "Worse" side.
0 other companies' latest entry also says "Reframed".
- FY2018ReframedAnnual report
「Depending on trends in stock markets, foreign exchange rates and interest rates, declines in the fair value of securities and other assets held, increases in the import prices of raw materials and other items, and increases in retirement benefit obligations and interest expenses may materially affect the Group's financial results and financial position.」
Organized the risks as financial market risks encompassing stocks, foreign exchange, interest rates, import prices and retirement benefit obligations. The disclosure also describes a hedging policy using foreign exchange contracts and interest rate swaps. - FY2016First statedAnnual report
「The Group primarily holds shares, including foreign shares, in business partners and alliance partners on a long-term basis. Valuation losses may arise due to stock market trends or foreign exchange fluctuations, potentially affecting the Group's financial results.」
Identifies valuation losses on cross-shareholdings and other holdings, as well as fluctuations in stock markets and foreign exchange rates, as risks.